Pitocin is a prescription injectable medication containing oxytocin, used to induce or strengthen labor by stimulating uterine contractions. It is administered intravenously and manufactured by Endo USA, Inc. This information was generated using AI and is provided for informational and research purposes only.

Corpus-verified analysis of 299 PubMed studies on Oxytocin. Includes evidence scores, target interactions, pathway associations, and research domain classification.

A collection of 22 brain maps. Each brain map is a 3D array of values representing properties of the brain at different locations.

Collection description

All 22 component maps included in: "Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women." http://biorxiv.org/content/early/2016/08/09/068585

Chemical Interactions for Oxytocin curated by BioGRID (https://thebiogrid.org); DEFINITION: Synthetic 9 residue cyclic peptide. The hormone is prepared synthetically to avoid possible contamination with vasopressin (ADH) and other small polypeptides with biologic activity.

Abstract: Affectionate touch, which is vital for mental and physical health, was restricted during the Covid-19 pandemic. This study investigated the association between momentary affectionate touch and subjective well-being, as well as salivary oxytocin and cortisol in everyday life during the pandemic. In the first step, we measured anxiety and depression symptoms, loneliness, and attitude toward social touch in a large cross-sectional online survey (N=1,050). From this sample, N=247 participants completed ecologically momentary assessments (EMA) over two days with six daily assessments by answering smartphone-based questions on affectionate touch and momentary mental state and providing concomitant saliva samples for cortisol and oxytocin assessment. Multilevel models showed that on a within-person level, affectionate touch was associated with decreased self-reported anxiety, general burden, stress, and increased oxytocin levels. On a between-person level, affectionate touch was associated with decreased cortisol levels and higher happiness. Moreover, individuals with a positive attitude towards social touch experiencing loneliness reported more mental health problems. Our results suggest that affectionate touch is linked to higher endogenous oxytocin in times of pandemic and lockdown and might buffer stress on a subjective and hormonal level. These findings might have implications for preventing mental burden during social contact restrictions.

Per-batch lab-verified Certificates of Analysis for Oxytocin: purity, endotoxin, sterility, heavy-metal results, and vendor attribution.

A collection of 56 brain maps. Each brain map is a 3D array of values representing properties of the brain at different locations.

Collection description

This collection includes unthresholded maps for all the analyses conducted in the study. Only the conjunction maps are presented thresholded at voxel level p=0.002.

The size of the Oxytocin Supplement market was valued at USD 90 million in 2023 and is projected to reach USD 153.25 million by 2032, with an expected CAGR of 7.9% during the forecast period.

The Oxytocin Market Report is Segmented by Indication (Antepartum, Postpartum), Route of Administration (Parenteral, Intranasal, Oromucosal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

The dataset contains the files (DARE_Workfile, Empathy_Workfile) used for the analyses of the study published by Fragkaki and Cima (2019) in Psychoneuroendocrinology. The study examined the effect of oxytocin administration on empathy and emotion recognition in 100 male adolescents living in residential youth care facilities. The study had a randomized, double-blind, placebo-controlled, within-subject design. The study included 3 sessions: screening session and two experimental sessions. In the experimental sessions, the participants received oxytocin in one session and placebo in the other session and performed the same experimental tasks on empathy and emotion recognition 30 min after administration. The order of the sprays as well as the order of the tasks were randomized using computer randomization. We performed mixed modeling to examined the effect of oxytocin on the outcome variables. The file “Documentation-ReadMe” describes the trial information, methodology, and the variables included in the datasets. The file "icu_dutch" is the Dutch version of the Inventory of callous-unemotional traits, the file ctq_dutch" is the Dutch version of the Childhood trauma questionnaire", and the file "ades_dutch" is the Dutch version of the Adolescent dissociative experiences scale.

299 indexed PubMed studies on Oxytocin

The oxytocin market was valued at $1.52 billion in 2025 and is projected to reach $2.54 billion by 2034, growing at 5.8% CAGR.

This study examined oxytocin expression in experimental models of Alzheimer’s disease (AD), and evaluated the therapeutic potential of treatment with oxytocin. They investigated changes in oxytocin expression in APP/PS1 mouse model and developed a chronic intranasal treatment protocol to increase oxytocin levels in the brain. Then, tested oxytocin as a potential approach to attenuate microglial activation and reverse memory deficits. This dataset includes source data used to assemble different figures in the publication. The source data contains data about hypothalamic expression of oxytocin is reduced in AD models, chronic intranasal administration of oxytocin increases hippocampal oxytocin and attenuates fear response in mice, cellular and molecular impact of intranasal oxytocin in APP/PS1 mouse brains, oxytocin attenuates AβO-induced microglial activation in vitro, and intranasal oxytocin reverses social and non-social memory deficits in aged APP/PS1 mice.

Global trade data of Oxytocin under 30049099000, 30049099000 global trade data, trade data of Oxytocin from 80+ Countries.

The global oxytocin testing kits market is anticipated to reach USD 1,351.4 million by 2035, rising from USD 740.5 million in 2025 at a 6.2% CAGR.

Top Countries Manufacturing, Distributing, and Scaling Oxytocin Testing Kits

Oxytocin is a neuropeptide released in the central nervous system, which is involved in a wide range of behaviors including reproduction, parental care, and pair bonding. In addition, peripheral oxytocin is important for milk ejection during nursing and uterine contractions during labor. Oxytocin is produced mainly in the paraventricular nucleus (PVN) and supraoptic nucleus of the hypothalamus. This study describes a neural circuit routing auditory information about infant vocalizations to mouse oxytocin neurons. They performed in vivo electrophysiological recordings and photometry from identified oxytocin neurons in awake maternal mice presented with pup calls. For this study, they made cell-attached and whole-cell recordings from PVN oxytocin neurons and other optically-unresponsive PVN neurons in awake head-fixed mouse dams. The dataset contains electrophysiology, behavioral, histology, and fiber photometry data. This study reveals a circuit that unlocks central oxytocin release and maternal behavior in response to pup calls.

Fighting is a major means to compete for limited resources in the wild. After the fight ends, the loser continuously avoids close interaction with the winner and readily flees when confronted. The neural mechanisms that underlie the rapid and long-lasting behavioral changes induced by defeat remains unclear. This study identified oxytocin neurons in the retrochiasmatic supraoptic nucleus and oxytocin-receptor-expressing cells in the anterior subdivision of the ventromedial hypothalamus as a key circuit motif for defeat-induced social avoidance through a series of functional manipulation and recording experiments in mice. The dataset contains fiber photometry recording data, behavior annotations, tracking, and raw representative histology images. These data reveal the crucial role of oxytocin in social behavior plasticity and expanded the list of regions through which oxytocin can modulate negative social responses.

Oxytocin Supplement Market size, share, and trend analysis indicates growth from USD 351 Million in 2025 to USD 895 Million by 2035, at a CAGR of 9.8%

Oxytocin Supplement Market Overview: Oxytocin Supplement Market Overview: The Oxytocin Supplement Market Size was valued at 704.6 USD Million in 2024. The Oxytocin Supplement Market is expected to grow from 754.6 USD Million in 2025 to 1,500 USD Million by 2035. The Oxytocin Supplement Market CAGR (growth rate) is expected to be around 7.1% during the forecast period (2025 - 2035). Key Oxytocin Supplement Market Trends Highlighted The global oxytocin supplement market is experiencing notable trends driven primarily by increasing awareness surrounding mental health and the role of hormones in well-being. Many consumers are becoming more health-conscious and are seeking natural alternatives to support emotional balance, leading to a surge in interest in oxytocin supplements. Additionally, the rise in online health and wellness platforms is facilitating easier access to these supplements, encouraging their adoption among diverse demographic groups. There are significant opportunities to be explored in the market, particularly in the fields of maternal health and postnatal care.As more research highlights the benefits of oxytocin in managing conditions such as Postpartum Depression and anxiety, healthcare providers are increasingly recommending these supplements as part of holistic treatment plans. This creates a pathway for manufacturers to innovate and target their products toward specific health needs, enhancing the overall market potential. In recent times, trends indicate a focus on Personalized Nutrition , with consumers seeking tailored solutions that address individual hormonal imbalances. This shift is prompting companies within the global market to develop products that cater to specific age groups or health conditions, thus broadening their appeal.Additionally, the growing trend of wellness tourism has resulted in increased interest in holistic health approaches, where oxytocin supplements are positioned as part of a broader package to promote overall wellness. Overall, the global oxytocin supplement market is poised for growth, driven by a convergence of health consciousness, innovative product development, and opportunities within specific health sectors. The increasing recognition of the supplement's benefits in various health programs is likely to support this market's trajectory toward a significant market size in the coming years. Source: Primary Research, Secondary Research, WGR Database and Analyst Review Oxytocin Supplement Market Segment Insights: Oxytocin Supplement Market Regional Insights The Global Oxytocin Supplement Market exhibits significant regional variations, with North America leading the valuation, achieving 267 USD Million in 2024 and projected to reach 546 USD Million in 2035. This region's strong growth is primarily driven by increasing awareness among consumers regarding the benefits of oxytocin supplements, along with advancements in product formulations. Europe follows a similar trend with steady expansion, characterized by rising health consciousness and a growing geriatric population in need of such supplements.In South America, there is moderate increase, driven by an emerging interest in natural supplements but constrained by economic factors. Meanwhile, the Asia Pacific region shows promising potential, with anticipated advancements in healthcare infrastructure contributing to significant uptake of oxytocin supplements. The Middle East and Africa, while currently holding lesser value, are expected to witness gradual growth owing to the increasing adoption of health and wellness trends. Overall, the fluctuations in the regional dynamics of the Global Oxytocin Supplement Market indicate both challenges and opportunities for stakeholders aiming to harness the market growth. Source: Primary Research, Secondary Research, WGR Database and Analyst Review • North America : The North American oxytocin supplement market is driven by increasing healthcare awareness, with substantial growth in the healthcare sector focusing on mental health and wellness. Legislative policies promoting health supplements, such as the Dietary Supplement Health and Education Act, enhance market growth. The region has seen a surge in consumer interest toward natural supplements. • Europe : Europe's oxytocin supplement market is influenced by stringent regulations around health products and a rising trend toward preventative health approaches. The European Food Safety Authority enforces robust policies ensurin

A collection of 3 brain maps. Each brain map is a 3D array of values representing properties of the brain at different locations.

Collection description